Navigation Links
Poniard Completes Patient Enrollment Target in Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer
Date:3/25/2009

SOUTH SAN FRANCISCO, Calif., March 25 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced that it has reached its enrollment target of 400 patients in the SPEAR (Study of Picoplatin Efficacy After Relapse) trial. This global, pivotal Phase 3 trial is evaluating the efficacy and safety of picoplatin in patients with recurrent small cell lung cancer (SCLC) who have failed prior platinum-containing first-line chemotherapy or who have progressed within six months of first-line therapy. Patients have been enrolled at more than 100 clinical trial sites in 16 countries in Europe, South America and Asia.

"Completion of patient enrollment in our pivotal Phase 3 SPEAR trial represents an important milestone for Poniard. We accomplished this ahead of internal projections, which allows us to keep on schedule to complete the clinical data analysis and initiate the filing of a rolling New Drug Application with the U.S. Food and Drug Administration for picoplatin in SCLC this year," said Jerry McMahon, Ph.D., chairman and chief executive officer of Poniard. "We believe that picoplatin will provide a survival benefit for SCLC patients who have failed platinum-based therapy consistent with survival data we have previously generated in two independent Phase 2 trials. We also expect the data will show that picoplatin overcomes resistance in patients treated with current platinum-based chemotherapies. This would be a new use for a platinum chemotherapy agent. We are also continuing to analyze additional clinical data from our picoplatin Phase 2 trials in first-line treatment for metastatic colorectal and prostate cancers and will report on them later this year."

"We are pleased to have completed trial enrollment ahead of schedule," said Robert De Jager, M.D.
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 A lot of discussion ... methods for treating  certain illnesses, injuries, or conditions. As medical ... previous treatment methods with ones that they consider to be ... there is not one textbook method of treatment that stands ...
(Date:1/23/2015)... new analysis of Centers for Medicare and Medicaid Services, ... 81 percent of seniors chose lower-cost preferred pharmacy plans ... pharmacies. The findings were released by Drug Channels ... foundation of Medicare Part D," said Pharmaceutical Care Management ...
(Date:1/23/2015)... More than a third of reproductive-aged women enrolled in Medicaid, ... filled a prescription for an opioid pain medication each year ... and Mortality Weekly Report (MMWR). Opioids are ... severe pain.  They are also found in some prescription cough ...
Breaking Medicine Technology:No One-Size-Fits-All Remedy for Hernia Correction 2New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... Sept. 30 ShowerBuddy, the newest addition to the ... creating headlines internationally. ShowerBuddy products, now available throughout North ... mind. Their basic premise holds that your shower or ... costly construction. Those planning to spend thousands on bathroom ...
... PAREXEL International Corporation (Nasdaq: PRXL ) announced today it ... Conference in New York, NY. James Winschel, Senior Vice ... presentation on PAREXEL at 3:30 p.m. EDT on Tuesday, October ... be available under the "Upcoming Events" section on PAREXEL,s "Investors" ...
Cached Medicine Technology:ShowerBuddy - Affordable, Accessible Bathing 2PAREXEL International to Present at William Blair Emerging Growth Stock Conference 2
(Date:1/22/2015)... January 22, 2015 EBSCO Information Services ... are expanding their relationship in an effort to further promote ... world. While EBSCO has long made AMA journals available via ... agent for The JAMA Network. , Long known ...
(Date:1/22/2015)... JJsHouse.com is a famous dress online store ... announces its latest collection of wedding dresses , and ... issue is the wedding dress on your big day; the ... life. Every bride wants to find the most suitable wedding ...
(Date:1/22/2015)... 22, 2015 Lower-Auto-Insurance.com has released a new blog ... a car for reducing the costs of an auto insurance ... be able to get lower prices for their vehicle insurance policies. ... role in determining policy costs. Because of this, drivers should ...
(Date:1/22/2015)... January 22, 2015 State Forestry Institute ... management system with support from GEOSYSTEMS, a dedicated Hexagon ... solution will leverage Hexagon Geospatial’s ERDAS APOLLO ... as well as point clouds and documents. This effort ...
(Date:12/26/2014)... is said that nothing makes a lady feel more feminine ... supplier, shows its new selection of navy cocktail dresses ... UWDress.com’s navy cocktail gowns are the cornerstones of the site’s ... Simple dresses in bright neon colors can be dressed up ...
Breaking Medicine News(10 mins):Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... Sisters, ,Grey,s Anatomy, and ,Samantha Who?, to be Honored at ... , LOS ANGELES, June 5 On June 13, Donate ... "Grey,s Anatomy" and "Samantha Who?" with its first annual Inspire ... transplant community, will be presented at the culmination of the ...
... 60% over teetotalers, researchers say , FRIDAY, June 5 (HealthDay ... and eating lots of red meat can raise the risk ... lifestyle factors that increase risk. , Drinking alcohol, smoking cigarettes ... who is going to develop colorectal cancer, study findings show. ...
... 5 Chandler Chicco Companies (CCC), an inVentiv Health (Nasdaq: ... the US launch of Brandtectonics Access, ... unique, tailored solutions to optimize patient access to pharmaceutical brands. ... will be headquartered in New York, while European operations are ...
... Executives for Medco Health Solutions, Inc. (NYSE: MHS ) are scheduled to ... Medco Chairman and CEO David B. Snow Jr. will address the ... on Tuesday, June 9, 2009 at 2:35 ... Glenn Taylor, Medco,s group president for key accounts, will address, ...
... 5 Helen Darling, President of the National Business Group ... Board of Directors of WorldatWork on June 2 at their ... honor granted by the association to an individual in recognition ... resources, total rewards, compensation and benefits. , , ...
... , 107 health centres and 680 pharmacies in the region ... , MADRID, June 5 The Extremadura Regional Government of ... an electronic prescription system in 680 pharmacies in Extremadura, where ... prescribe and dispense prescription medications electronically. , , ...
Cached Medicine News:Health News:ABC-TV Gets It Right According to Organ Donation Community 2Health News:Alcohol, Cigarettes and Diabetes Up Colorectal Cancer Risk 2Health News:Chandler Chicco Companies Announces New Brandtectonics Access US Offering 2Health News:Chandler Chicco Companies Announces New Brandtectonics Access US Offering 3Health News:Medco to Present at June 2009 Investor Conferences 2Health News:WorldatWork Honors Helen Darling, NBGH President, with Prestigious Keystone Award 2Health News:Spain's Regional Extremadura Government Launches Electronic Prescription System With IBM 2
Two opposing 62 mirrors provide a complete view of the anterior chamber angle with only a 180 lens rotation. Methylcellulose and no methylcellulose designs available....
Direct gonioscopy lens with magnification. The lens rests on the scleral flange creating a corneal vault and leaving the anterior chamber angle undisturbed. Three sizes available....
Mcintyre straight lachrymal cannula, closed end, two side ports at 0.3 mm, straight shaft....
Bailey lachrymal cannula, 7 mm exposed tip, 8 mm reinforced....
Medicine Products: